1. Shinji Tanaka. Invited Lecture; Stemness and heterogeneity of liver cancer. JSH International Liver Conference 2021 2021.10.02 Hakata International Exhibition Hall & Conference Center, Fukuoka (on-line)

  2. Hiroyuki Ishida, Hiroki Ueda, Keiichi Akahoshi, Yoshiya Ishikawa, Hironari Yamashita, Koichiro Morimoto, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Early recurrence after curative hepatectomy for colorectal liver metastases. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  3. Yoshiya Ishikawa, Hiroyuki Ishida, Koichiro Morimoto, Hironari Yamashita, Hiroki Ueda, Keiichi Akahoshi, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma using supracolic anterior approach to the superior mesenteric artery. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  4. Takeshi Ishii, Atsushi Kudo, Yoshiki Murase, Aya Maekawa, Toshitaka Sugawara, Yoshiya Ishikawa, Shuichi Watanabe, Hiroki Ueda, Keiichi Akahoshi, Kousuke Ogawa, Hiroaki Ono, Shinji Tanaka, Minoru Tanabe. The management of GEP-NET with MEN type 1 in our department. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  5. Koichiro Morimoto, Keiichi Akahoshi, Hironari Yamashita, Hiroyuki Ishida, Kohei Yagi, Aya Maekawa, Yoshiki Murase, Takeshi Ishii, Toshitaka Sugawara, Yoshiya Ishikawa, Hiroki Ueda, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Granulomatous Langerhans isletitis followed by nivolumab-induced type 1 diabetes mellitus in a distal pancreatectomy: case report. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  6. Hiroki Ueda, Koichiro Morimoto, Hironari Yamashita, Hiroyuki Ishida, Kohei Yagi, Aya Maekawa, Yoshiki Murase, Toshitaka Sugawara, Takeshi Ishii, Yoshiya Ishikawa, Keiichi Akahoshi, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Perioperative outcomes in elderly patients over 75-years-old undergoing distal pancreatectomy. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  7. Hiroaki Ono, Atsushi Kudo, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Kosuke Ogawa, Shinji Tanaka, Minoru Tanabe. Combination of Weekly Streptozocin and Oral S-1 Treatment is effective treatment for unresectable or metastatic pancreatic NET-G1 and NET-G2 patients. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  8. Hironari Yamashita, Keiichi Akahoshi, Koichirou Morimoto, Hiroyuki Ishida, Kohei Yagi, Aya Maekawa, Yoshiki Murase, Takeshi Ishii, Toshitaka Sugawara, Yoshiya Ishikawa, Hiroki Ueda, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Effect of neoadjuvant chemotherapy on short-term outcome in patients undergoing pancreaticoduodenectomy for borderline resectable pancreatic cancer and resectable pancreatic cancer with elevated serum tumor markers. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  9. Kohei Yagi, Hiroki Ueda, Koichiro Morimoto, Hironari Yamashita, Yoshiki Murase, Aya Maekawa, Takeshi Ishii, Toshitaka Sugawara, Shuichi Watanabe, Yoshiya Ishikawa, Keiichi Akashoshi, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, SHinji Tanaka, Minoru Tanabe. A review of resected cases of primary duodenal cancer in our hospital. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  10. Yoshiki Murase, Hiroaki Ono, Risa Yoshioka, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Kosuke Ogawa, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. High Eg5 expression predicts poor prognosis in pancreatic cancer. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  11. Aya Maekawa, Keiichi Akahoshi, Yoshiya Ishikawa, Hiroki Ueda, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Validation of the international consensus guideline 2017 for intraductal papillary mucinous neoplasms. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  12. Keiichi Akahoshi, Yoshiya Ishikawa, Hiroki Ueda, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Conversion surgery after lenvatinib treatment for advanced hepatocellular carcinoma. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  13. Ueda Hiroki, Morimoto Koichiro, Yamashita Hironari, Ishida Hiroyuki, Yagi Kohei, Maekawa Aya, Murase Yoshiki, Sugawara Toshitaka, Ishii Takeshi, Ishikawa Yoshiya, Akahoshi Keiichi, Ogawa Kosuke, Ono Hiroaki, Kudo Atsushi, Tanaka Shinji, Tanabe Minoru. 75歳以上の高齢患者に対する膵体尾部切除術の周術期成績(Perioperative outcomes in elderly patients over 75-years-old undergoing distal pancreatectomy). 日本肝胆膵外科学会・学術集会プログラム・抄録集 2021.06.01

  14. Ishii Takeshi, Kudo Atsushi, Murase Yoshiki, Maekawa Aya, Sugawara Toshitaka, Ishikawa Yoshiya, Watagebe Shuichi, Ueda Hiroki, Akahoshi Keiichi, Ogawa Kousuke, Ono Hiroaki, Tanaka Shinji, Tanabe Minoru. MEN type 1を伴うGEP-NETの管理(The management of GEP-NET with MEN type1 in our department). 日本肝胆膵外科学会・学術集会プログラム・抄録集 2021.06.01

  15. Tomotaka Kato, Yoshiya Ishikawa, Shuichi Watanabe, Keiichi Akahoshi, Kosuke Ogawa, Hiroaki Ono, Daisuke Ban, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Comparison of open and laparoscopic hepatectomy for obese patients with HCC. The 33rd Annual Meeting of the Japan Society for Endoscopic Surgery 2021.03.10 Yokohama

  16. Kohei Yagi, Atsushi Kudo, Aya Maekawa, Yoshiki Murase, Takeshi Ishii, Tomotaka Kato, Masafumi Akasu, Toshitaka Sugawara, Yoshiya Ishikawa, Shuichi Watanabe, Keiichi Akahoshi, Ogawa Kosuke, Hiroaki Ono, Daisuke Ban, Shinji Tanaka, Minoru Tanabe. Evaluation of laparoscopic distal pancreatectomy for pancreatic neuroendocrine tumors. The 32nd Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2021.02.23 Web

  17. Keiichi Akahoshi, Kohei Yagi, Yoshiki Murase, Takeshi Ishii, Toshitaka Sugawara, Yoshiya Ishikawa, Shuichi Watanabe, Kosuke Ogawa, Hiroaki Ono, Daisuke Ban, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Non-viral hepatocellular carcinoma and, diabetes and obesity as its risk factorslar carcinoma and, diabetes and obesity as its risk factors. The 32nd Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2021.02.23 Web

  18. Hiroaki Ono, Tomotaka Kato, Aya Maekawa, Kouhei Yagi, Yoshiya Ishikawa, SHuichi Watanabe, Keiichi Akahoshi, Kousuke Ogawa, Daisuke Ban, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Cytoplasmic RRM1 activation in acute phase of gemcitabine treatment is involved in acquired resistance of pancreatic cancer. The 32nd Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2021.02.23 Web

  19. Takeshi Ishii, Keiichi Akahoshi, Kohei Yagi, Aya Maekawa, Yoshiki Murase, Toshitaka Sugawara, Masafumi Akasu, Tomotaka, Kato, Yoshiya Ishikawa, Shuichi Watanabe, Kousuke Ogawa, Hiroaki Ono, Daisuke Ban, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Clinical Analysis of 23 Cases of total pancreatectomy in Tokyo Medical and Dental University. The 32nd Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2021.02.23 Web

  20. Shuichi Watanabe, Shu Shimada, Jo NIshino, Kohei Yagi, Aya Maekawa, Yoshiki Murase, Toshitaka Sugawara, Takeshi Ishii, Tomotaka Kato, Masafumi Akasu, Yoshiya Ishikawa, Keiichi Akahoshi, Kosuke Ogawa, Hiroaki Ono, Daisuke Ban, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Estimation of the type of HCC metastasis based on the multicellular colonization model. The 32nd Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2021.02.23 Web

  21. Keiichi Akahoshi, Yoshiya Ishikawa, Hiroki Ueda, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Liver resection after systemic chemotherapy improved overallsurvival of metastatic neuroendocrine neoplasms. The 32nd Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2021.02.23 Web

  1. 秋山好光, 吉野潤, 島田周, 田邊稔, 田中真二. ARID1A欠失胆管癌における幹細胞遺伝子ALDH1A1の発現亢進とヒストン修飾変化の関与. 第22回日本肝がん分子標的治療研究会 2020.11.14 金沢

  1. Shuichi Watanabe, Daisuke Ban,Toshiro Ogura,Kosuke Ogawa, Hiroaki Ono,Yusuke Mitsunori,Atsushi Kudo,Shinji Tanaka,Minoru Tanabe. The analysis of the treatment for the metachronous solitary metastasis after curative surgery in pancreatic cancer. The 31st Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2019.06.14 Takamatsu

  2. Toshitaka Sugawara,Daisuke Ban,Takeshi Ishii,Satoshi Matsui,Masahumi Akasu,Tomotaka Kato,Daisuke Asano,Jun Yoshino,Shuichi Watanabe, Toshiro Ogura,Kosuke Ogawa, Hiroaki Ono,Yusuke Mitsunori,Atsushi Kudo,Shinji Tanaka,Minoru Tanabe. Preoperative factors for early recurrence of resected pancreatic ductal adenocarcinoma. The 31st Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2019.06.14 Takamatsu

  3. Takeshi Ishii,Toshiro Ogura,Yoshiki Murase,Toshitaka Sugawara,Masahumi Akasu, Tomotaka Kato,Jun Yoshino,Shuichi Watanabe, Kosuke Ogawa, Hiroaki Ono,Yusuke Mitsunori,Daisuke Ban,Atsushi Kudo,Shinji Tanaka,Minoru Tanabe. Surgery for obese patients with hepatocellular carcinoma. The 31st Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2019.06.13 Takamatsu

  1. Tomotaka Kato、Daisuke Ban、Keiichi Akahoshi、Toshiro Ogura、Kosuke Ogawa、Hiroaki Ono、Yusuke Mitsunori、Atsushi Kudo、Shinji Tanaka、 Minoru Tanabe . Treatment strategies of resectable pancreatic cancer with hazy density around major artery. The 73rd General Meeting of the Japanese Society of Gastroenterological Surgery 2018.07.12 Kagoshima

  2. Shuichi Watanabe、Shu Shimada、Yoshimitsu Akiyama、Kosuke Ogawa、Hiroaki Ono、Yusuke Mitsunori、Daisuke Ban、Atsushi Kudo、Minoru Tanabe、Shinji Tanaka. Precision medicine for the poorest prognosis subtype of pancreatic cancer. The 73rd General Meeting of the Japanese Society of Gastroenterological Surgery 2018.07.12 Kagoshima

  3. Yusuke Mitsunori,Masafumi Akasu,Tomotaka Kato,Jun Yoshino, Shuichi Watanabe,Norimichi Chiyonobu,Keiichi Akahoshi,Toshiro Ogura,Kosuke Ogawa, Hiroaki Ono, Daisuke Ban, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. What is predictive factor of postoperative diabetes mellitus in patients with distal pancreatectomy?. The 30th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2018.06.09 yokohama

  4. Toshiro Ogura, Tomotaka Kato, Masafumi Akasu, Jun Yoshino, Shuichi Watanabe, Norimichi Chiyonobu, Yuki Mizuno, Keiichi Akahoshi, Kosuke Ogawa, Hiroaki Ono, Yusuke Mitsunori,Daisuke Ban, Atsushi Kudo,Shinji Tanaka, Minoru Tanabe. The implication of lymph node metastasis on survival in cases with distal pancreatic cancer. The 30th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2018.06.09

  5. Shuichi Watanabe, Atsushi Kudo, Masafumi Akasu, Tomotaka Kato, Jun Yoshino, Norimichi Chiyonobu, Yuki Mizuno, Keiichi Akahoshi, Kosuke Ogawa, Toshiro Ogura, Yusuke Mitsunori, Hiroaki Ono, Daisuke Ban, Shinji Tanaka, Minoru Tanabe. The efficacy of liver SASI test for the the advanced functional PNET patients. The 30th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2018.06.09 yokohama

  6. Jun Yoshino,Toshiro Ogura,Keiichi Akahoshi,Kosuke Ogawa, Yusuke Mitsunori,Hiroaki Ono, Daisuke Ban, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Long-term outcomes and prognostic factors of patients with gallbladder cancer resection. The 30th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2018.06.08

  7. Akasu Masafumi, Kudo Atsushi, Kato Tomotaka, Yoshino Jun, Watanabe Shuichi, Chiyonobu Norimichi, Mizuno Yuki, Akahoshi Keichi, Ogura Toshiro, Ogawa Kosuke, Ono Hiroaki, Mitsunori Yusuke, Ban Daisuke, Tanaka Shinji, Tanabe Minoru. P-NETに対する分子標的薬の治療成績(The results of molecular targeted drugs to P-NET). 日本肝胆膵外科学会・学術集会プログラム・抄録集 2018.06.01

  8. Minoru Tanabe, Toshiro Ogura, Atsushi Kudo, Daisuke Ban, Shinji Tanaka. Surgery for Obese Patients with HCC. APASL2018 2018.05.12 Yokohama

  9. Tomotaka Kato,Atsushi Kudo, Hiroaki Ono, Masahumi Akasu, Jun Yoshino, Kosuke Ogawa, Toshiro Ogura , Yusuke Mitsunori, Daisuke Ban, Shinji Tanaka,Minoru Tanabe. A Surgical Case of Spontaneous and Asymptomatic Intrahepatic Hemorrhage with HCC. APASL2018 2018.05.12 Yokohama

  1. Fukamachi H, Nishikawaji T, Shimada S, Akiyama Y, Yuasa Y, Tsuchiya K, Tanaka S. . Identification of signal transduction pathway in PDX-derived diffuse-type gastric tumor-initiating cells.. 第76回日本癌学会総会 2017.09.30 横浜

  2. Akiyama Y, Nishikawaji T, Shimada S, Yuasa Y, Tanaka S.. Molecular mechanisms of SETDB2 histone methyltransferase overexpression in gastric cancer.. 第76回日本癌学会総会 2017.09.30 横浜

  3. Shimada S, Akiyama Y, Tanaka S.. Acquired resistance with epigenetic alterations under long-term anti-angiogenic therapy for hepatocellular carcinoma.. 第76回日本癌学会総会 2017.09.28 横浜

  4. 光法雄介,赤星径一,巌康仁,小野宏晃,松村聡,伴大輔,落合高徳,工藤篤,田中真二,田邉稔. 胆肝細胞癌の局在はリンパ節郭清の適応や範囲の判断基準になりうるか. 第72回日本消化器外科学会総会 2017.07.21

  5. 渡辺 秀一. 再発形式による膵癌術後再発例の予後の差異の検討. 第72回日本消化器外科学会総会 2017.07.20

  6. Takehisa Yazawa、Hiroaki Ono¹、Yasuhito Iwao、Satoshi Matsumura、Yusuke Mitsunori、Daisuke Ban、Takanori Ochiai、Atsushi Kudo、Shinji Tanaka、Minoru Tanabe. Clinical significance of enhancing nodules in preoperative imaging studies of IPMN. 6th A-PHPBA 29th JSHBPS 2017.06.10 yokohama

  7. Takehiro Okabayashi、Daisuke Asano、Keiichi Akahoshi、Hiroaki Ono、Yusuke Mitsunori、Atsushi Kudo、Shinji Tanaka、Minoru Tanabe. The optimal management depending on the features of CT imaging of borderline resectable pancreatic cancer. 6th A-PHPBA & 29th JSHBPS 2017.06.09

  8. Ken-ichi Okada、Daisuke Ban、Keiichi Akahoshi、Yasuhito Iwao、Hiroaki Ono、Yusuke Mitsunori、Satoshi Matsumura、Atsushi Kudo、Shinji Tanaka、Minoru Tanabe. The optimal pancreatic stump closure method of a laparoscopic distalpancreatectomy: wrapping and fibrin capping technique. 6th A-PHPBA & 29th JSHBPS 2017.06.09

  9. Hiroki Ueda、Daisuke Ban、Atsushi Kudo、Takanori Ochiai、Shinji Tanaka、Minoru Tanabe . Refractory long-term cholangitis after pancreaticoduodenectomy: a retrospective study . 6th A-PHPBA & 29th JSHBPS   2017.06.09 yokohama

  10. Shuichi Watanabe、Daisuke Ban、Yasuhito Iwao、Keiichi Akahoshi、Akihiro Ono、Yusuke Mitsunori、Satoshi Matsumura、Takanori Ochiai、Atsushi Kudo、Shinji Tanaka、Minoru Tanabe. Study of the prognosis of recurrent pancreatic cancer: The significance of the solitary recurrence. 6th A-PHPBA & 29th JSHBPS 2017.06.08 yokohama

  11. Atsushi Kudo、Daisuke Ban、Keiichi Akahoshi、Yusuke Mitsunori、Shinji Tanaka、Minoru Tanabe. Systemic therapy may decide surgical indication for patients with Unresectable of Metastatic Pancreatic Neuroendocrine Tumor. 6th A-PHPBA & 29th JSHBPS 2017.06.08

  12. Atsushi Kudo、Daisuke Ban、Keiichi Akahoshi、Satoshi Matsumura、Yusuke MItsunori、Yasuhito Iwao、Shinji Tanaka、Minoru Tanabe. How to manage liver metastases of pancreatic NET?. 6th A-PHPBA & 29th JSHBPS 2017.06.08 yokohama

  13. Yusuke Mitsunori、Daisuke Ban、Hiroaki Ono、Keiichi Akahoshi、Yasuhito Iwao、Satoshi Matsumura、Takanori Ochiai、Atsushi Kudo、Shinji Tanaka、Minoru Tanabe. Can we predict postoperative diabetes mellitus in patient with distal pancreatectomy?. 6th A-PHPBA 29th JSHBPS 2017.06.08 yokohama

  14. Hiroaki Ono、Keiichi Akahoshi、Yasuhito Iwao、Satoshi Matsumura、Yuusuke Mitsunori、Daisuke Ban、Takanori Ochiai、Atsushi Kudo、Shinji Tanaka、Minoru Tanabe. Clinical evaluation of lymph node metastasis after surgery of IPMN. 6th A-PHPBA 29th JSHBPS 2017.06.08 yokohama

  15. 田中 真二, 島田 周, 秋山 好光, 松村 聡, 光法 雄介, 藍原 有弘, 落合 高徳, 伴 大輔, 工藤 篤, 有井 滋樹, 田邉 稔. Precision medicine bench to bedside 肝胆膵がんの分子サブタイプと治療抵抗性解析によるprecision medicineの展開. 日本外科学会定期学術集会抄録集 2017.04.01

  16. Ochiai T, Asano D, Yoshino J, Watanabe S, Ishikawa Y, Chiyonobu N, Mizuno Y, Sato T, Ueda H, Iwao Y, Ono H, Mitsunori Y, Matsumura S, Ban D, Kudo A, Tanaka S, Tanabe M. Surgical Strategy of Hepatic Resection with Inferior Vena Cava Resection for Liver Cancers. 12th Annual Academic Surgical Congress 2017.02.07 Las Vegas, USA

  1. Akiyama Y, Nishikawaji T, Shimada S, Deng D, Kim WH, Zhu WG, Yuasa Y, Tanaka S. Expression changes of the histone H3 lysine methyltransferase genes and their function in gastric cancer. 5th International Cancer Epigenetics Meeting 2016.10.22 Beijing, China

  2. Fukamachi H, Nishikawaji T, Shimada S, Akiyama Y, Yuasa Y, Tsuchiya K, Tanaka S. Characteristics of diffuse-type gastric cancer stem cells. 26th Seoul International Cancer Symposium 2016.06.17 Seoul, Korea

  3. Akiyama Y, Nishikawaji T, Shimada S, Yuasa Y, Tanaka S. Expression changes of the histone methyltransferase genes, SETDB2, in gastric cancers. 26th Seoul International Cancer Symposium 2016.06.17 Seoul, Korea

  4. Akiyama Y, Nishikawaji T, Shimada S, Sakamoto A, Deng D, Kim WH, Zhu WG, Yuasa Y Tanaka S. Reduced expression and its function of SET7/9, a histone methyltransferase gene, in gastric cancer. The 35th Sapporo International Cancer Symposium 2016 2016.05.24

  5. Shimada S, Akiyama Y, Fukamachi H, Yuasa Y, Tanaka S. Identification of selective inhibitors of diffuse-type gastric cancer cells by screening annotated compounds. AACR Annual Meeting 2016 2016.04.18 New Orleans, LA

  1. Tanaka S, Ogawa K, Matsumura S, Aihara A, Ban D, Ochiai T, Irie T, Kudo A, Arii S, Tanabe M. A preclinical study of EpCAM-targeted therapy for human hepatocellular carcinoma with stem cell features. 65th Annual Meeting of the American Association for the Study of Liver diseases 2014.11.10 Boston, USA

  2. Katsuta E, Kudo A, Ohata Y, Ueda H, Sato A, Oba A, Akahoshi K, Nakao K, Furuyama T,Ito H, Matsumura S, Aihara A, Ban D, Ochiai T, Irie T, Tanaka S, Tanabe M.. Morphology of pancreatic Neuroendocrine Tumor(P-NET). American Pancreatic Association 2014.11.08 Hawaii

  3. Akiyama Y, Koda Y, Nishikawaji T, Shimada S, Deng D, Kim WH, Zhu WG, Yuasa Y. Altered expression of the histone methyltransferase genes in gastric cancer.. 4th International Cancer Epigenetics Meeting 2014.10.19 Yangzhou, China

  4. Hiroki Ueda, Daisuke Ban, Yoshiteru Ohata, Taku Sato, Atsushi Ohba, Keiichi Akahoshi, Takaki Furuyama, Hiromitsu Ito, Keisuke Nakao, Eriko Katsuta, Satoshi Matsumura, Yusuke Mitsunori, Arihiro Aihara, Takanori Ochiai Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. The optimal dividing line of the jejunum for pancreatoduodenectomy. The Scientific Meeting of Japan-Hungary-Poland Surgical Society [Triangle Symposium 2014] 2014.10.18 Tokyo

  5. Tanaka S. “Novel molecular targets and therapeutic combinations in hepatocellular carcinoma; rationale and significance” (invited lecture). 4th International Kyoto Liver Cancer Symposium 2014.06.08 Kyoto

  6. Tanaka S, Ogawa K, Murakata A, Mogushi K, Matsumura S, Aihara A, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Tanaka H, Arii S, Tanabe M. Preclinical studies of EpCAM-targeted therapy for human hepatocellular carcinoma with specific inhibition of stem cell features. 105th Annual Meeting of the American Association for Cancer Research 2014.04.06 San Diego, USA

  7. T. Ochiai, A. Shioya, H. Honma, Y. Saitoh, S. Matsumura, D. Ban, T. Irie, A. Kudo, N. Nakamura, T. Fujikawa, A. Itai, S. Tanaka, S. Arii, S. Yamaoka, M. Tanabe . Combination Treatment of IκB Kinase β Inhibitor IMD-0354 and Gemcitabine Suppresses Oncogenic Proliferation of Pancreatic Cancer Cells. 9th Annual Academic Surgical Congress 2014.02.04 San Diego, USA

  1. Shimada S. Targeting Epigenetic Alterations in a Mouse Model of E-cadherin/p53-deficient Diffuse-type Gastric Cancer.. The 4th JCA-AACR Special Joint Conference 2013.12

  1. Akiyama Y, Koda Y, Nishikawaji T, Shimada S, Zhu WG, Yuasa Y.. Loss of SET7, a histone H3K4 methyltransferase, in gastric cancer.. The 3rd International Cancer Epigenetics Meeting 2012.10 東京

  2. Akiyama Y, Nagasaki H, Yuasa Y.. Target gene analysis of GATA4 and GATA5 transcription factors in gastric cancer cells.. The 10th Japan-Korea Joint Symposium on Cancer and Ageing 2012.02 東京

  1. Shimada S, Mimata A, Mogushi K, Akiyama Y, Fukamachi H, Jonkers J, Tanaka H, Eishi Y, Yuasa Y. Mouse model of diffuse-type gastric cancer by conditional inactivation of E-cadherin and p53.. IGCC 2011 - 9th International Gastric Cancer Congress - NRF A3 Foresight Program 2011.04

  2. Akiyama Y, Nagasaki H, Yuasa Y. . Epigenetic alterations of GATA4 and GATA5 transcription factors in gastric cancers.. NRF A3 Foresight Program – IGCC2011 2011.04

  1. Akiyama Y, Nagasaki H, Yuasa Y. . Hypermethylation of GATA4 and GATA5 transcription factor genes and loss of their functions in gastric cancers.. The Second International Cancer Epigenetics Symposium 2010.10

  2. Akiyama Y, Nagasaki H, Yuasa Y. . Target gene analysis of GATA4/5 transcription factors in gastric cancers.. The 5th Asian Epigenomics Meeting & A3 Symposium 2010 2010.06 Jeju, 韓国

  3. Akiyama Y, Nagasaki H, Kawamoto A, Herman JG, Baylin SB, Yuasa Y.. Methylation of GATA4 and GATA5 transcription factor genes in gastric cancers.. 101st AACR Annual Meeting 2010.04 Washington DC, USA

  1. Akiyama Y, Hashimoto Y, Yuasa Y. . Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis.. The 9th Korea-Japan Symposium on Cancer and Ageing Research 2009.09 Damyang, 韓国

  2. 秋山好光、長崎弘美、湯浅保仁. . 胃がんにおける転写関連遺伝子GATA4/5のメチル化異常と機能解析.. 第3回日本エピジェネティクス研究会年会 2009.05 東京

  1. Akiyama Y, Wanajo A, Otsubo T, Nagasaki H, Yuasa Y.. Promoter hypermethylation of the calcium channel-related gene, CACNA2D3, is frequent and an independently poor prognostic factor in gastric carcinomas.. AACR Annual Meeting 2008 2008.04 San Diego, USA

  1. Akiyama Y, Yuasa Y. Hypermethylation of GATA4 and GATA5 transcription factor genes in gastric cancer. . The 12th Korea-Japan Cancer Research Workshop 2007.12

  2. Akiyama Y, Nagasaki H, Kawamoto A, Yuasa Y. GATA4 and GATA5 transcription factor genes were frequently silenced by methylation in gastric cancer. . The 8th Korea-Japan Joint Symposium on Cancer and Ageing Research 2007.08 岐阜

  1. 秋山好光、和南城愛良、佐々木茜、長崎弘美、湯浅保仁. 胃癌における電位依存性カルシウムチャンネル関連遺伝子のメチル化の解析.. 第65回日本癌学会総会 2006.09 横浜

  2. Akiyama Y, Wanajo A, Sasaki A, Yuasa Y. requent methylation of the calcium channel-related gene, CACNA2D3, in gastric cancers.. AACR, 97th Annual Meeting 2006.04 Washington DC, USA

  1. Akiyama Y, Wen X-Z & Yuasa Y. Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas. . The 7th Korea-Japan Joint Symposium on Cancer and Ageing Research 2005.11 Muju, 韓国

  1. Akiyama Y, Yuasa Y, Herman JG & Baylin SB. GATA–4 and GATA-5 transcription factor genes and potential downstream anti-tumor target genes are epigenetically silenced in colorectal and gastric cancer.. 6th Japan-Korea Workshop on Cancer and Aging Research 2004.02 徳島

  1. Shinji Tanaka. JCA-Mauverney Award Session Invited Lecture; Surgical oncology to develop novel targeted and immunotherapies for hepato-biliary-pancreatic cancer. 80th Annual Meeting of Japanese Cancer Association 2021.10.02 Yokohama

  2. Shu Shimada, Shinji Tanaka.. Establishment of molecular-immunological subtypes and development of specific models for therapeutic application in hepatocellular carcinoma.. The 80th Annual Meeting of the Japanese Cancer Association. 2021.09.30 Yokohama

  1. Shu Shimada, Yoshimitsu Akiyama, Shigeki Arii, Minoru Tanabe, Shinji Tanaka. Comprehensive molecular and immunological classification of hepatocellular carcinoma. The 56th Annual Meeting of Liver Cancer Study Group of Japan 2020.12.22 Online

  2. Akiyama Y, Shimada S, Tanabe M, Tanaka S. Loss of ARID1A increases a stemness gene ALDH1A1 expression through histone acetylation change in cholangiocarcinoma. The 79th Annual Meeting of the Japanese Cancer Association 2020.10.01 Yokohama, Online

  3. Shimada S, Akiyama Y, Tanabe M, Tanaka S. Loss of KDM6A characterizes a poor prognostic subtype of pancreatic cancer and potentiates HDAC inhibitor lethali . The 79th Annual Meeting of the Japanese Cancer Association 2020.10.01 Yokohama, Online

  4. Shimada S, Akiyama Y, Tanaka S. Loss of KDM6A characterizes a poor prognostic subtype of pancreatic cancer and potentiates HDAC inhibitor lethality . The 23rd Frontier Scientists Workshop, Post A3-2020 Symposium on Epigenetic Signature of Carcinogenesis 2020.09.19 Seoul, Korea, Online

  5. Fukiko Kawai-Kitahata, Yasuhiro Asahina , Sei Kakinuma, Miyako Murakawa, Sayuri Nitta, Masato Miyoshi, Ayako Sato, Jun Tsuchiya, Taro Shimizu, Eiko Takeichi, Mina Nakagawa, Yasuhiro Itsui, Seishin Azuma, Shinji Tanaka , Minoru Tanabe, Shinya Maekawa, Nobuyuki Enomoto and Mamoru Watanabe.. Comprehensive analysis of cancer-related genes and aav/hepatitis b virus integration into genome on development of hepatocellular carcinoma in patients with prior hepatitis b virus infection.. EASL The Digital International Liver Congress 2020 2020.08.28 Online

  1. Shinji Tanaka, Shuichi Watanabe, Minoru Tanabe.. Novel genetic and immunological classification of hepatocellular carcinoma for the subtype-specific precision immunotherapy. JAPAN DIGESTIVE DISEASE WEEK 2019 2019.11.22 Kobe

  2. Yoshimitsu Akiyama, Shu Shimada, Shinji Tanaka. Overexpression of histone arginine methyltransferase PRMT6 contributes to prognosis and malignancy of gastric cancer. The 78th Annual Meeting of the Japanese Cancer Association 2019.09.27 Kyoto

  3. Shu Shimada, Yoshimitsu Akiyama, Shinji Tanaka. Comprehensive molecular and immunological characterization of hepatocellular carcinoma. The78th Annual Meeting of the Japanese Cancer Association 2019.09.26 kyoto

  4. Asymmetric dimethylation at histone H3 arginine 2 by PRMT6 in gastric cancer progression. 2019.05.28

  1. Yoshimitsu Akiyama, Shu Shimada, Minoru Tanabe, Shinji Tanaka. DAXX acts as a tumor suppressor through histone H3.3/H3K9me3 pathway in pancreatic neuroendocrine tumors. The 77th Annual Meeting of the Japanese Cancer Association 2018.09.29 Osaka

  2. Shinji Tanaka. Molecular target therapy under precision medicine. 77th Annual Meeting of Japanese Cancer Association 2018.09.28 Osaka

  3. Shu Shimada, Norimichi Chiyonobu, Yoshimitsu Akiyama, Shinji Tanaka. FABP4 overexpression in intratumoral hepatic stellate cells within hepatocellular carcinoma with metabolic risk factors.. The 77th Annual Meeting of the Japanese Cancer Association 2018.09.28 Osaka

  4. Yuki Mizuno, Shu Shimada, Yoshimitsu Akiyama, Shuichi Watanabe,Tomomi Aida, Kosuke Ogawa,Hiroaki Ono, Yusuke Mitsunori,Daisuke Ban, Atsushi Kudo, Shoji Yamaoka, Shinji Tanaka, Minoru Tanabe. DEPDC5 deficiency contributes to resistance to leucine starvation via p62 accumulation in hepatocellular carcinoma. 2018.09.28

  5. Shinji Tanaka, Atsushi Oba, Shu Shimada, Yoshimitsu Akiyama, Kosuke Ogawa, Hiroaki Ono, Yusuke Mitsunori, Daisuke Ban, Atsushi Kudo, Shigeki Arii, Minoru Tanabe. Precision immunotherapy for hypermutator and immunogenic subtypes of hepatocellular carcinoma. 73rd General Meeting of the Japanese Society of Gastroenterological Surgery 2018.07.12 Kagoshima

  6. Shinji Tanaka. Precision medicine for HCC and pancreatic cancer . The 7th International Forum of The Japanese Society of Gastroenterology Jointly with the 12th International Symposium on ALPD and Cirrhosis 2018.04.19 Tokyo

  1. Shu Shimada, Yoshiteru Ohata, Yoshimitsu Akiyama, Shinji Tanaka. Acquired resistance with epigenetic alterations under long-term anti-angiogenic therapy for hepatocellular carcinoma. The 76th Annual Meeting of the Japanese Cancer Association 2017.09.28 Yokohama

  2. Tanaka S, Oba A, Ogawa Y, Ono H, Mitunori Y, Ban D, Kudo A, Arii S, Tanabe M. . Personalized medicine to target the cancer stemness of hepato-biliary-pancreatic malignancies (Symposium).. The 72rd General Meeting of the Japanese Society of Gastroenterological Surgery 2017.07.22 Kanazawa

  3. Tanaka S, Shimada S, Akiyama Y, Muramatu S, Mitumori Y, Aihara A, Ocjoai T, Ban D, Kudo A, Arii S, Tanabe M.. Significance of molecular subtypes and therapeutic resistance mechanisms in hepato-biliary-pancreatic malignancies for precision cancer medicine . The 117th Annual Congress of Japan Surgical Society 2017.04.27 Yokohama

  1. Shimada S, Akiyama Y, Fukamachi H, Yuasa Y, Tanaka S. Identification of selective inhibitors of diffuse-type gastric cancer cells by screening of annotated compounds. The 75th Annual Meeting of the Japanese Cancer Association 2016.10.07 Yokohama

  2. Akiyama Y, Nishikawaji T, Shimada S, Sakamoto A, Yuasa Y, Tanaka S. Reduced expression of SET7/9, a histone mono-methyltransferase, is associated with gastric cancer progression. The 75th Annual Meeting of the Japanese Cancer Association 2016.10.07 Yokohama

  3. Nishikawaji T, Akiyama Y, Shimada S, Yuasa Y, Tanaka S. SETDB2 contributes to gastric cancer progression by deregulating the expression of tumor suppressor genes. The 75th Annual Meeting of the Japanese Cancer Association 2016.10.06 Yokohama

  4. Fukamachi H, Nishikawaji T, Shimada S, Akiyama Y, Yuasa Y, Tanaka S. Identification of MTDs that suppress the growth of PDX-derived duffuse-type gastric tumor-initiating cells. The 75th Annual Meeting of the Japanese Cancer Association 2016.10.06 Yokohama

  5. Tanaka S, Shimada S, Akiyama Y. Epigenetic target of stemness for metastasis and therapeutic resistance in patients with pancreatic and liver cancers. The 75th Annual Meeting of the Japanese Cancer Association 2016.10.06 Yokohama

  6. Tanaka S, Ito H, Furuyama T, Aihara A, Matsumura S, Mitsunori Y, Ban D, Ochiai T, Kudo A, Tanabe M. Personalized medicine to target the cancer stemness of hepato-biliary-pancreatic malignancies (Symposium).. The 72th Annual Meeting of the Japanese Society of Gastroenterological Surgery 2016.07.15 Tokushima

  7. Akiyama Y, Nishikawaji T, Shimada S, Sakamoto A, Deng D, Kim WH, Zhu WG, Yuasa Y, Tanaka S. Reduced expression and its function of SET7/9, a histone methyltransferase gene, in gastric cancer. The 35th Sapporo International Cancer Symposium 2016.06.24 Sapporo

  1. Tanaka S. Surgical oncology for identification of novel molecular targets in refractory cancers (symposium). The 74th Annual Meeting of the Japanese Cancer Association 2015.10.09 Nagoya

  2. Sakamoto A, Shimada S, Akiyama Y, Yuasa Y, Tanaka S. Epigenetic regulation of Twist1 in diffuse-type gastric cancer cell lines of an E-cadherin/p53-deficient mouse model. The 74th Annual Meeting of the Japanese Cancer Association 2015.10.09 Nagoya

  3. Nishikawaji T, Akiyama Y, Shimada S, Yuasa Y, Tanaka S. Oncogenic roles of SETDB2, a histone methyltransferase, in human gastric carcinogenesis. The 74th Annual Meeting of the Japanese Cancer Association 2015.10.09 Nagoya

  4. Akiyama Y, Koda Y, Nishikawaji T, Shimada S, Sakamoto A, Yuasa Y, Tanaka S. Transcriptional regulatory mechanism of SET7/9 in gastric cancer. The 74th Annual Meeting of the Japanese Cancer Association 2015.10.09 Nagoya

  5. Tanaka S, Aihara A, Tanabe M. Molecular pathogenesis and targeted therapy for major vascular invasiveness of hepatocellular carcinoma (symposium). The 13th General Meeting of the Japanese Society of Gastroenterological Surgery 2015.10.08 Tokyo

  1. Tanaka S, Adikrisna R, Mogushi K, Matsunaga H, Matsumura S, Aihara A, Ochiai T, Tanaka H, Yamaoka S, Arii S. Visualized cancer stem cells for analysis of heterogenic expansion and microenvironments with tumor-host interaction (symposium). The 73th Annual Meeting of the Japanese Cancer Association 2014.09.25 Yokohama

  2. Tanaka S, Aihara A, Matsumura S, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Arii S, Tanabe M. Molecular targeted therapy for major vascular invasiveness of hepatocellular carcinoma (symposium). The 26th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2014.06.12 Wakayama

  3. Aurora /VEGF-R2 dual kinase inhibitor as a novel treatment for hepatocellular carcinoma. 2014.04.04

To the head of this page.▲